Dose Escalation Trial of Endoluminal High-Dose-Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative Management

Name: Dose Escalation Trial of Endoluminal High-Dose-Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative Management
Published: 2014
License: Public Domain

Memorial Sloan Kettering Cancer Center · 2014

ClinicalTrials.gov · Datasets · License: Public Domain · 2014

Open Source ↗

questionnaires

rectal or anal cancer, high-dose-rate brachytherapy, oral capecitabine, infusional 5-fu, questionnaires, 14-104, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Dose Escalation Trial of Endoluminal High-Dose-Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative Management

Related documents